Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vivienne Carduz Castilho"'
Autor:
Adriana Orcesi Pedro, Samantha Belamarques de Oliveira Silva, Maura Gonzaga Lapa, Juliana Dineia Perez Brandao, Vivienne Carduz Castilho
Publikováno v:
Global Journal of Medical Research. :1-8
Background: Evaluate the prevalence, intensity and regional distribution of premenstrual syndrome (PMS) symptoms reported by reproductive age Brazilian women. Methods: An observational and retrospective study was conducted analyzing data of women fro
Autor:
Adriana Orcesi Pedro, Achilles Machado Cruz, Lara Lopes Faco, Angélica Richart Csipak, Cassio Yooiti Yamakawa, Vivienne Carduz Castilho
Publikováno v:
Brazilian Journal of Health Review; Vol. 5 No. 5 (2022); 20418-20431
Brazilian Journal of Health Review; v. 5 n. 5 (2022); 20418-20431
Brazilian Journal of Health Review
Federação das Indústrias do Estado do Paraná (FIEP)
instacron:BJRH
Brazilian Journal of Health Review; v. 5 n. 5 (2022); 20418-20431
Brazilian Journal of Health Review
Federação das Indústrias do Estado do Paraná (FIEP)
instacron:BJRH
Objectives: To evaluate the effectiveness and acceptability of a new vaginal moisturizer composed of a combination of humectants, moisturizers, bioadhesives, and viscosity polymers (sodium hyaluronate 0.1%, polycarbophil 1.5%, carbomer 1.5%, and glyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0cb7cc67dc1a1376716849f5a0a7b2
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/52961
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/52961
Autor:
Vivienne Carduz Castilho, Gustavo Facchini, Ana Lucia Tabarini Alves Pinheiro, Angélica Richart Csipak, Samara Eberlin, Camila Martins Kawakami, Gustavo Henrique da Silva, Liliana Bechelli de Oliveira Torloni
Publikováno v:
Dermatology and Dermatitis. 6:01-08
People suffering from an ordinary acute cold consume so many handkerchiefs that the wiping actions on their own increase the abrasive damage of the nasolabial zone, finally leading to a disturbed barrier function and inflamation. It seems that the qu
Autor:
Franklin Fernandes Pimentel, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, João Gonçalves, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho, Roger Chammas, Juliano Simões de Toledo
Publikováno v:
Mastology.
Objectives: Trastuzumab and pertuzumab bind to HER2 synergistically at different subdomains, improving the clinical benefit of breast cancer treatment. Recently, trastuzumab biosimilars were approved after comparison with the originator, proving high
Autor:
Ana Carolina Ferreira Cardoso, Debora De Melo Gagliato, Natália Mesquita Brito, Maura Gonzaga Lapa, Érida Aparecida Pinto Magaton, Renata Virgínia Cavalcanti Santos, Vivienne Carduz Castilho
Publikováno v:
Journal of Clinical Oncology. 40:e12524-e12524
e12524 Background: The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) defines a biosimilar as a biological molecule product that is highly similar to and has no clinically meaningful differences from an existing approved
Autor:
Fernanda Cristina Silva, Fatima Gandufe, Ana Carolina Cardoso, Augusto Theodoro Figueiredo, Leandro Ladislau Alves, Alexandre Alcantara, Vivienne Carduz Castilho, Lara Lopes Facó, Rafaella Rodrigues
Publikováno v:
Journal of Clinical Oncology. 38:e13023-e13023
e13023 Background: Real-World Evidence (RWE) are gain importance once they are designed to evaluate the effectiveness of drugs whose efficacy has already been demonstrated in randomized controlled trials. In 2017, Brazil approved the first biosimilar
Autor:
Paola Cardoso, Alexandre Alcantara, Ana Carolina Cardoso, Vivienne Carduz Castilho, Leandro Ladislau Alves, Heloisa Magda Resende, Lara Lopes Facó, Pedro Henrique Adário Marassi, Maristela Precivale
Publikováno v:
Journal of Clinical Oncology. 38:e13010-e13010
e13010 Background: Brazil has a complex health-care system which comprises 76% of population in the public unified health system (SUS) and only 24% in private system. Even with most of the population in the public system low resources has been alloca
Autor:
Mayara I de Paula, Maristela Precivale, Alexandre Alcantara, Leandro Ladislau Alves, Vivienne Carduz Castilho, Ana Carolina Cardoso, Debora de Melo Gagliato
Publikováno v:
Cancer Research. 80:OT2-01
Background: Treatment with anti-HER2 therapy significantly improved survival outcomes in patients with HER2-positive Breast Cancer (BC). In Brazil, Trastuzumab was the first biosimilar approved in the treatment of patients with breast (any disease se